Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06394908
Other study ID # MIUS.2022.001
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date May 10, 2023
Est. completion date May 2027

Study information

Verified date April 2024
Source Marmara University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this registry is to collect data on patients who have undergone minimally invasive treatments for urinary system stone disease, including percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), and flexible ureterorenoscopy (F-URS).


Description:

In this project, the Minimally Invasive Urology Association urolithiasis study group aimed to collect the data of adult and pediatric urinary system stone patients treated with PCNL, SWL, URS, and F-URS in a non-randomized, observational, and prospective manner. The registry was to be conducted multi-center in Turkey. In this project, Excel files were created and shared via Google Drive with the responsible physicians at the centers to be included in the study. Each parameter was prepared in an explanatory manner and can be readily filled out by physicians familiar with these methods. The ability to examine and modify existing data will be restricted to the worker and the database administrator. Patients' identities will not be revealed in the registry. The collected data are summarized in three sections under the major headings below; 1. Demographics and preoperative information; Patient, disease, and treatment method demographic data, such as age, gender, height, weight, previous diseases, medications used, location, size, and hardness of urinary tract stones, the side of the stone, and the methods used for diagnosis, will be prospectively recorded for patients whose consent was obtained. 2. Data during the operation; The duration of the operation as well as the devices and methods utilized will be recorded. 3. In the postoperative period, post-treatment findings, such as stone-free status and post-treatment complications, will be documented. A separate application to the ethics committee will be submitted for each study on the subject that will be created in the future from the multi-center, prospectively recorded data pool and on the subject that will be investigated.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 10000
Est. completion date May 2027
Est. primary completion date May 2025
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - To have a medical indication for urolithiasis - Complete data of treatment and follow-up course - Patients with consent - Patients > 18 years-old - Patients < 18 years-old Exclusion Criteria: - Missing data - Patients without consent - Not to have a medical indication for urolithiasis treatment - To have a contraindication for urolithiasis treatment

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Marmara University Hospital Istanbul

Sponsors (12)

Lead Sponsor Collaborator
Marmara University Alanya Alaaddin Keykubat University, Baskent University, Cukurova University, Dokuz Eylul University, Gazi University, Hitit University, Koç University, Mugla Sitki Koçman University, Necmettin Erbakan University, Ondokuz Mayis University, Samsun Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Operative durations of each treatment technique (PCNL, SWL, URS, F-URS) The duration of the operation time Operation/procedure day
Primary Operative radiation dosage of each treatment technique (PCNL, SWL, URS, F-URS) X-ray dosage Operation/procedure day
Primary Operative results of each treatment technique (PCNL, SWL, URS, F-URS) The duration of the laser time Operation/procedure day
Primary Postoperative results Postoperative estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2) immediately after procedure
Primary Rate of postoperative complication Abnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up up to 3 months, postoperatively
Primary Follow-up Follow-up results of patients for recurrence of disease of residual stones, if any reoperation records. up to 10 years
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04746378 - PRedictive Accuracy of Initial Stone Burden Evaluation.
Recruiting NCT05100017 - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure N/A
Recruiting NCT04021381 - Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi Phase 3
Completed NCT02266381 - A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy N/A
Completed NCT01451931 - Study of Tomography of Nephrolithiasis Evaluation Phase 4
Terminated NCT01431378 - Pilot Study of Model Based Iterative Reconstruction Using 64-Slice N/A
Completed NCT02895711 - Radiation Dose of Pediatric Patients During Ureteroscopy
Completed NCT01295879 - Vitamin D Repletion in Stone Formers With Hypercalciuria Phase 4
Completed NCT05340075 - Staged Bilateral Percutaneous Nephrolithotomy
Recruiting NCT03919227 - Measurement of Resistance During UAS Insertion Procedure in RIRS N/A
Recruiting NCT03717285 - Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS N/A
Completed NCT05340088 - Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Not yet recruiting NCT04080973 - Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia N/A
Terminated NCT01736358 - The Use of Intranasal Ketoralac for Pain Management (Sprix) Phase 4
Completed NCT01792765 - Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach N/A
Completed NCT06211842 - Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
Not yet recruiting NCT02214836 - Ultrasound Imaging of Kidney Stones and Lithotripsy N/A
Not yet recruiting NCT04606758 - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease N/A